why choose us

Clinical Trials Search

Showing 18,260 of 132,963 result(s)
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors

Status: Completed

Condition: Solid Tumor

Interventions: In the escalation part, patients will receive a single dose of oral ABSK121-NX on Day -7 followed by a 7-day washout (Day -7 dosing day as 1st day of

Date: 2022-11-15

PrEP Optimization Among Women to Enhance Retention and Uptake

Status: Completed

Condition: PrEP Uptake

Interventions: Education for participants regarding PrEP

Date: 2022-11-15

Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts

Status: Completed

Condition: Breast Cancer

Interventions: In addition to their standard, digital breast tomosynthesis mammogram (DBT) performed at their regular screening visits, all participants will also re

Date: 2022-11-15

Disulfiram for Treatment of Retinal Degeneration

Status: Completed

Condition: Inherited Retinal Dystrophy Primarily Involving Sensory Retina

Interventions: Disulfiram treatment

Date: 2022-11-15

Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Status: Completed

Condition: Diffuse Large B-Cell Lymphoma

Interventions: Intravenous infusion

Date: 2022-11-15

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Status: Completed

Condition: Geographic Atrophy

Interventions: OpRegen dose up to approximately 200,000 cells will be delivered into the subretinal space

Date: 2022-11-15

Mindfulness Training Versus Low (FODMAP) Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols Diet

Status: NOT_YET_RECRUITING

Condition: Irritable Bowel Syndrome (IBS)

Interventions: The MB-IBS-EAT is an 8-week intervention with weekly 1-hour sessions in a web-based group format.

Date: 2022-11-15

How to Get Started: Identifying the Critical Ingredients to Improve Gait Initiation in Parkinson Disease

Status: COMPLETED

Condition: Parkinson Disease

Interventions: Visual cues to improve amplitude of weight shift prior to initiating gait.

Date: 2022-11-15

Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors

Status: Completed

Condition: Neuroendocrine Tumors

Interventions: Patients with positive uptake on FDA approved SSTR2 PET;CT will receive a fixed dose of [212Pb]VMT-?-NET IV administered every 8 weeks for a maxi

Date: 2022-11-15